Rigel Pharmaceuticals (RIGL) Enterprise Value Growth (1y) (2011 - 2026)
Rigel Pharmaceuticals (RIGL) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -90.25% |
| Dec 31, 2025 | -100.40% |
| Sep 30, 2025 | -124.41% |
| Jun 30, 2025 | -120.72% |
| Mar 31, 2025 | -55.60% |
| Dec 31, 2024 | -35.81% |
| Sep 30, 2024 | 1.98% |
| Jun 30, 2024 | 23.70% |
| Mar 31, 2024 | 15.53% |
| Dec 31, 2023 | 2.19% |
| Sep 30, 2023 | 23.63% |
| Jun 30, 2023 | 27.82% |
| Mar 31, 2023 | 45.44% |
| Dec 31, 2022 | 53.42% |
| Sep 30, 2022 | 42.97% |
| Jun 30, 2022 | 41.87% |
| Mar 31, 2022 | -173.27% |
| Dec 31, 2021 | -117.99% |
| Sep 30, 2021 | -96.60% |
| Jun 30, 2021 | -65.83% |